Status:
COMPLETED
A Novel Method to Improve Acne Outcomes
Lead Sponsor:
Wake Forest University
Conditions:
Acne Vulgaris
Eligibility:
All Genders
13-18 years
Phase:
NA
Brief Summary
This is an investigator-blinded, prospective study of 20 subjects aged 13 through 18 with mild to moderate acne. Study subjects will be randomized to an internet survey group, in which an email link f...
Eligibility Criteria
Inclusion
- male or female 13 to 18 years of age with a diagnosis of mild to moderate acne vulgaris by a dermatologist.
- written consent of participation must be given by parent or guardian and child.
Exclusion
- Age less than 13 or greater than 18 years of age.
- Known allergy or sensitivity to topical benzoyl peroxide gel in the subject.
- Inability to complete all study-related visits.
- Introduction of any other prescription medication, topical or systemic, for acne vulgaris while participating in the study.
- Subjects may not use topical retinoids or other benzoyl peroxide products, including Proactiv® or topical prescription medications while enrolled in the study.
- Women that are actively trying to become pregnant or wish to become pregnant during the time frame the study is to take place will be excluded.
- Subjects will be carefully selected for this study and only those deemed appropriate for treatment with benzoyl peroxide will be placed on this medication.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01176955
Start Date
May 1 2009
End Date
August 1 2010
Last Update
August 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences, Department of Dermatology
Winston-Salem, North Carolina, United States, 27157